• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜癌:组织病理学分级和肿瘤细胞类型评估的争议。

Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.

机构信息

Department of Pathology and Laboratory Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada.

出版信息

J Clin Pathol. 2010 May;63(5):410-5. doi: 10.1136/jcp.2009.071225.

DOI:10.1136/jcp.2009.071225
PMID:20418232
Abstract

Histopathological assessment of tumour grade and cell type is central to the management of endometrial carcinoma, guiding the extent of surgery and the use of adjuvant radiation therapy and chemotherapy. Endometrioid carcinomas are usually low grade but high-grade examples are encountered, and they have a significantly worse prognosis, similar to that of high-grade subtypes such as serous and clear cell carcinoma. This article reviews the various grading systems that have been proposed for use with endometrioid endometrial carcinoma, and discusses the recent progress in cell type assignment, including the use of immunohistochemistry as a diagnostic adjunct.

摘要

肿瘤分级和细胞类型的组织病理学评估是子宫内膜癌管理的核心,指导手术范围以及辅助放疗和化疗的应用。子宫内膜样癌通常为低级别,但也会出现高级别病例,其预后明显较差,与高级别亚型(如浆液性和透明细胞癌)相似。本文回顾了用于子宫内膜样子宫内膜癌的各种分级系统,并讨论了细胞类型分配的最新进展,包括免疫组织化学作为诊断辅助的应用。

相似文献

1
Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.子宫内膜癌:组织病理学分级和肿瘤细胞类型评估的争议。
J Clin Pathol. 2010 May;63(5):410-5. doi: 10.1136/jcp.2009.071225.
2
Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.卵巢癌的形态学亚型:新进展和发病机制综述。
Pathology. 2011 Aug;43(5):420-32. doi: 10.1097/PAT.0b013e328348a6e7.
3
Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.p16 表达在鉴别子宫浆液性癌与子宫内膜样腺癌和宫颈内膜腺癌中的作用:201 例免疫组化分析。
Am J Surg Pathol. 2009 Oct;33(10):1504-14. doi: 10.1097/PAS.0b013e3181ac35f5.
4
Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.与高危型子宫内膜上皮癌相比,子宫内膜癌肉瘤具有不同的预后和扩散模式。
Gynecol Oncol. 2005 Aug;98(2):274-80. doi: 10.1016/j.ygyno.2005.04.027.
5
Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.子宫内膜癌:强调重叠和独特形态及免疫组织化学特征的综述。
Adv Anat Pathol. 2011 Nov;18(6):415-37. doi: 10.1097/PAP.0b013e318234ab18.
6
HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.HMGA2 在子宫浆液性癌中普遍表达,是诊断的有用辅助手段。
Histopathology. 2012 Mar;60(4):547-53. doi: 10.1111/j.1365-2559.2011.04105.x. Epub 2012 Jan 17.
7
[Histologic diagnosis of endometrial cancer].[子宫内膜癌的组织学诊断]
Nihon Rinsho. 2004 Oct;62 Suppl 10:309-12.
8
IMP2 expression distinguishes endometrioid from serous endometrial adenocarcinomas.IMP2 表达可区分子宫内膜样癌与浆液性子宫内膜腺癌。
Am J Surg Pathol. 2011 Jun;35(6):868-72. doi: 10.1097/PAS.0b013e318219c6f9.
9
Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.免疫组织化学鉴定典型的子宫内膜透明细胞癌——HNF-1β 和雌激素受体的诊断效用。
Histopathology. 2014 Mar;64(4):585-96. doi: 10.1111/his.12286. Epub 2013 Dec 7.
10
Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium.区分低级别子宫内膜样腺癌和浆液性癌的策略。
Adv Anat Pathol. 2012 Jan;19(1):1-10. doi: 10.1097/PAP.0b013e318234ab36.

引用本文的文献

1
Establishment and validation of a prognostic nomogram for overall survival in type II endometrial carcinoma patients.II型子宫内膜癌患者总生存预后列线图的建立与验证
Sci Rep. 2025 Mar 6;15(1):7801. doi: 10.1038/s41598-025-91261-z.
2
New clinicopathological concept of endometrial carcinoma with integration of histological features and molecular profiles.子宫内膜癌的新临床病理概念:组织学特征与分子谱的整合。
Pathol Int. 2024 Oct;74(10):557-573. doi: 10.1111/pin.13471. Epub 2024 Aug 22.
3
Deep Learning for Grading Endometrial Cancer.
深度学习在子宫内膜癌分级中的应用。
Am J Pathol. 2024 Sep;194(9):1701-1711. doi: 10.1016/j.ajpath.2024.05.003. Epub 2024 Jun 13.
4
Heterogeneous Profile of ROR1 Protein Expression across Tumor Types.跨肿瘤类型的ROR1蛋白表达的异质性概况。
Cancers (Basel). 2024 May 15;16(10):1874. doi: 10.3390/cancers16101874.
5
Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells.糖代谢和脂代谢相关基因预测子宫内膜癌的预后及其对肿瘤细胞的影响。
BMC Cancer. 2024 May 8;24(1):571. doi: 10.1186/s12885-024-12327-1.
6
Assessing the New 2020 ESGO/ESTRO/ESP Endometrial Cancer Risk Molecular Categorization System for Predicting Survival and Recurrence.评估2020年新的欧洲妇科肿瘤学会/欧洲放射肿瘤学会/西班牙妇科肿瘤学会子宫内膜癌风险分子分类系统对生存和复发的预测能力
Cancers (Basel). 2024 Feb 27;16(5):965. doi: 10.3390/cancers16050965.
7
Automated facial expression measurement in a longitudinal sample of 4- and 8-month-olds: Baby FaceReader 9 and manual coding of affective expressions.4 个月和 8 个月大的纵向样本中的自动面部表情测量:Baby FaceReader 9 和情感表达的手动编码。
Behav Res Methods. 2024 Sep;56(6):5709-5731. doi: 10.3758/s13428-023-02301-3. Epub 2024 Jan 25.
8
Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced, Recurrent Endometrial Cancer: A Scoping Review with SWOT Analysis.针对晚期复发性子宫内膜癌中PD-1/PD-L1通路的免疫检查点抑制剂:一项基于SWOT分析的范围综述
Cancers (Basel). 2023 Sep 19;15(18):4632. doi: 10.3390/cancers15184632.
9
Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images.基于深度学习的卵巢癌全切片病理图像组织学分型诊断。
Mod Pathol. 2022 Dec;35(12):1983-1990. doi: 10.1038/s41379-022-01146-z. Epub 2022 Sep 5.
10
Improved preoperative risk stratification in endometrial carcinoma patients: external validation of the ENDORISK Bayesian network model in a large population-based case series.改善子宫内膜癌患者的术前风险分层:ENDORISK 贝叶斯网络模型在大型基于人群的病例系列中的外部验证。
J Cancer Res Clin Oncol. 2023 Jul;149(7):3361-3369. doi: 10.1007/s00432-022-04218-4. Epub 2022 Aug 8.